Vaginal Discharge clinical trials
The registry lists 21 studies for Vaginal Discharge across more than 10 countries. 2 are recruiting or about to start. 10 of them are mainly about Vaginal Discharge (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-21.
Get an email when these change. Save the Vaginal Discharge studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Atlantic Health System (3) · Perfect Care Distribution (3) · The University of Texas Health Science Center, Houston (1) · University of Alberta (1) · Turku University Hospital (1) · Azienda Sanitaria-Universitaria Integrata di Udine (1) · Bonafide Health (1) · CONRAD (1)
What is being tested here
Drugs under test in Vaginal Discharge studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Metronidazole | 0 | 1 | 3 |
| Secnidazole | 0 | 2 | 2 |
| Lidocaine | 0 | 1 | 1 |
| Estradiol | 0 | 0 | 1 |
| Clotrimazole | 0 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Sep 2027Vaginal and Oral Microbiome Crosstalk · Turku University Hospital
Who these studies take
Of the 1 Vaginal Discharge studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 1 (100%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 0 (0%) |
| 30 | 1 (100%) | 0 (0%) |
| 40 | 1 (100%) | 0 (0%) |
| 50 | 1 (100%) | 0 (0%) |
| 65 | 1 (100%) | 0 (0%) |
| 75 | 1 (100%) | 0 (0%) |
| 85 | 1 (100%) | 0 (0%) |
Across all 21 studies, recruiting or not: 43% stop at 75 or younger and 43% at 65; 5% take children; 100% are for women only and 0% for men only; 48% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 21 of 21. search them.
- Vaginal and Oral Microbiome CrosstalkRecruitingNCT028988181 country
- Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health ParametersNot yet recruitingNCT06530186Not applicable1 country
- The Effects of an Orally-Administered Probiotic on Vaginal SymptomsCompletedNCT07829861Not applicable1 country
- Cytolytic Vaginosis Multicentre RegistryCompletedNCT062284693 countries
- In-Clinic Assessment of Vaginal Mucosal Safety Following Repetitive Use of the Livi DeviceCompletedNCT07445958Not applicable1 country
- Point-of-care Tests for Vaginal Discharge in NepalActive, not recruitingNCT05977491Not applicable1 country
- Randomized, Double-Blind Placebo-Controlled Trial to Assess Overall User Experience of a Synbiotic Vaginal SuppositoryCompletedNCT06236893Not applicable1 country
- HPV Typing Between Self- and Physician-sampledCompletedNCT04472377Not applicable1 country
- Clinical Investigation To Evaluate Cerviron Ovules® in Symptomatic VaginitisCompletedNCT04735705Not applicable1 country
- A Phase 3 Study of Solosec® for the Treatment of TrichomoniasisCompletedNCT03935217Phase 31 country
- Efficacy and Safety of the Application of Local Anaesthetic in Spray to Repair of 1st- 2nd Perineal LacerationsCompletedNCT05201313Phase 31 country
- Real-world Performance and Safety of Cerviron® in the Treatment of VaginitisCompletedNCT056529591 country
- Postmenopausal Pessary Users: Estrogen Versus TrimosanTerminatedNCT03943823Phase 41 country
- RWE Study in the Treatment of Cervical Lesions of Various EtiologyCompletedNCT056688061 country
- Evaluation of a Novel Female Hygiene Device for Postcoital DiscomfortStatus unknownNCT04885556Not applicable1 country
- Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal TissueCompletedNCT01347632Not applicable1 country
- Validity of Patient-Collected Wet MountsCompletedNCT02641717Not applicable1 country
- Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.WithdrawnNCT02713139Phase 3
- Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal DischargeCompletedNCT02111629Phase 31 country
- A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean SectionsTerminatedNCT00528008Phase 31 country
- Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial VaginosisCompletedNCT01055106Phase 21 country